{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:54:03Z","timestamp":1775289243165,"version":"3.50.1"},"reference-count":137,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaad.2018.10.072","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T23:56:01Z","timestamp":1543449361000},"page":"23-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention"],"prefix":"10.1016","volume":"81","author":[{"given":"Uyen Ngoc","family":"Mui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Haley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"Vangipuram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen K.","family":"Tyring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 suppl","key":"10.1016\/j.jaad.2018.10.072_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1002\/hep.22881","article-title":"Hepatitis B: the virus and disease","volume":"49","author":"Liang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2018.10.072_bib2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2018.10.072_bib3","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.3748\/wjg.v20.i20.6236","article-title":"Role of hepatitis B virus DNA integration in human hepatocarcinogenesis","volume":"20","author":"Hai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2018.10.072_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmi.2015.06.026","article-title":"Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors","volume":"21","author":"Schinzari","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jaad.2018.10.072_bib5","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.3748\/wjg.v21.i38.10732","article-title":"Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis","volume":"21","author":"Geng","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2018.10.072_bib6","doi-asserted-by":"crossref","first-page":"E940","DOI":"10.3390\/ijms17060940","article-title":"Hepatitis B virus X protein and hepatocarcinogenesis","volume":"17","author":"Liu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2018.10.072_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1155\/2005\/450574","article-title":"The laboratory diagnosis of hepatitis B virus","volume":"16","author":"Krajden","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.jaad.2018.10.072_bib9","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2018.10.072_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11901-010-0041-7","article-title":"Pros and cons of peginterferon versus nucleos(t)ide analogues for treatment of chronic hepatitis B","volume":"9","author":"Sonneveld","year":"2010","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jaad.2018.10.072_bib11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/jvh.12738","article-title":"HBsAg loss after peginterferon-nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow-up","volume":"24","author":"Stelma","year":"2017","journal-title":"J Viral Hepat"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2018.10.072_bib12","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1002\/hep.22921","article-title":"Benefits and risks of combination therapy for hepatitis B","volume":"49","author":"Terrault","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2018.10.072_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.292.6514.159","article-title":"Antibody responses to recombinant and plasma derived hepatitis B vaccines","volume":"292","author":"Brown","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"suppl A","key":"10.1016\/j.jaad.2018.10.072_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0163-4453(86)92653-8","article-title":"Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose","volume":"13","author":"Davidson","year":"1986","journal-title":"J Infect"},{"key":"10.1016\/j.jaad.2018.10.072_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0264-410X(88)90173-9","article-title":"Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness","volume":"6","author":"Stephenne","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2018.10.072_bib16","series-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","article-title":"Hepatitis B","year":"2015"},{"key":"10.1016\/j.jaad.2018.10.072_bib17","first-page":"123","article-title":"Extrahepatic manifestations of acute hepatitis B virus infection","volume":"9","author":"Kappus","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jaad.2018.10.072_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.tvir.2014.11.005","article-title":"Polyarteritis nodosa","volume":"17","author":"Howard","year":"2014","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00005792-199509000-00002","article-title":"Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients","volume":"74","author":"Guillevin","year":"1995","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2018.10.072_bib20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaad.2005.09.033","article-title":"Gianotti-Crosti syndrome","volume":"54","author":"Brandt","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib21","series-title":"Hepatitis C Viruses: Genomes and Molecular Biology","article-title":"HCV genome and life cycle","author":"Chevaliez","year":"2006"},{"key":"10.1016\/j.jaad.2018.10.072_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3350\/cmh.2015.21.2.105","article-title":"Hepatitis C virus-induced hepatocellular carcinoma","volume":"21","author":"Goossens","year":"2015","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archderm.135.8.1000","article-title":"High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus","volume":"135","author":"Sookoian","year":"1999","journal-title":"Arch Dermatol"},{"issue":"3 suppl 1","key":"10.1016\/j.jaad.2018.10.072_bib24","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1002\/hep.510260720","article-title":"Side effects of alpha interferon in chronic hepatitis C","volume":"26","author":"Dusheiko","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2018.10.072_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1586\/14760584.8.3.333","article-title":"Development of hepatitis C virus vaccines: challenges and progress","volume":"8","author":"Stoll-Keller","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jaad.2018.10.072_bib26","first-page":"127","article-title":"Dermatologic extrahepatic manifestations of hepatitis C","volume":"3","author":"Dedania","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib27","first-page":"695","article-title":"Hepatitis C virus-related mixed cryoglobulinemia: pathogenesis, clinical manifestations, and new therapies","volume":"3","author":"Schamberg","year":"2007","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.jaad.2018.10.072_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000018059","article-title":"Prevalence of hepatitis C virus antibodies and cryoglobulinemia in patients with leukocytoclastic vasculitis","volume":"198","author":"G\u00fcng\u00f6r","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2018.10.072_bib29","article-title":"Porphyria diagnostics-part 1: a brief overview of the porphyrias","volume":"86","author":"Ramanujam","year":"2015","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.jaad.2018.10.072_bib30","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.4254\/wjh.v7.i27.2740","article-title":"Cutaneous manifestations of hepatitis C in the era of new antiviral agents","volume":"7","author":"Garcovich","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.amjms.2017.03.007","article-title":"Hepatitis C treatment in patients with porphyria cutanea tarda","volume":"353","author":"Singal","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaad.2018.10.072_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Ryan Caballes","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jaad.2018.10.072_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cld.2017.03.010","article-title":"Dermatologic manifestations of chronic hepatitis C infection","volume":"21","author":"Sayiner","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jaad.2018.10.072_bib34","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.3748\/wjg.14.5913","article-title":"Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C","volume":"14","author":"Azim","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2018.10.072_bib35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jamadermatol.2016.3036","article-title":"Resolution of porphyria cutanea tarda in patients with hepatitis C following ledipasvir-sofosbuvir combination therapy","volume":"152","author":"Tong","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib36","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/bjd.15502","article-title":"Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda","volume":"177","author":"Combalia","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaad.2011.11.963","article-title":"Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection","volume":"67","author":"Raphael","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1996.tb02997.x","article-title":"Necrolytic acral erythema: a cutaneous marker of viral hepatitis C","volume":"35","author":"el Darouti","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0019-5154.174047","article-title":"Necrolytic acral erythema in the absence of hepatitis C virus infection","volume":"61","author":"Das","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4103\/2229-5178.185464","article-title":"Seronegative necrolytic acral erythema: a report of two cases and literature review","volume":"7","author":"Pandit","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2018.10.072_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4103\/0019-5154.70676","article-title":"Seronegative necrolytic acral erythema: a distinct clinical subset?","volume":"55","author":"Panda","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib42","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.5070\/D31912020709","article-title":"Necrolytic acral erythema","volume":"19","author":"Yost","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2018.10.072_bib43","first-page":"1370","article-title":"Necrolytic acral erythema","volume":"11","author":"Grauel","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archderm.141.1.85","article-title":"Necrolytic acral erythema: a patient from the United States successfully treated with oral zinc","volume":"141","author":"Abdallah","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamadermatol.2015.3538","article-title":"Rapid clearance of necrolytic migratory erythema following intravenous administration of amino acids","volume":"152","author":"Thomaidou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib46","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","article-title":"Infective dermatitis of Jamaican children: a marker for HTLV-I infection","volume":"336","author":"La Grenade","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2018.10.072_bib47","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2018.10.072_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.coviro.2016.08.009","article-title":"Human T-cell leukemia virus-associated malignancy","volume":"20","author":"Panfil","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jaad.2018.10.072_bib49","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib50","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.bjc.6605345","article-title":"Mechanisms of HTLV-1 persistence and transformation","volume":"101","author":"Boxus","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2018.10.072_bib51","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T-lymphotropic virus type I infection","volume":"353","author":"Manns","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2018.10.072_bib52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib54","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/DAD.0000000000000312","article-title":"Infective dermatitis in an adult patient with HTLV-1","volume":"37","author":"Di Martino Ortiz","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.10.072_bib55","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1590\/1806-9282.62.07.691","article-title":"Adult T-cell leukemia\/lymphoma","volume":"62","author":"Oliveira","year":"2016","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"10.1016\/j.jaad.2018.10.072_bib56","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2018.10.072_bib57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2018.10.072_bib58","first-page":"935","article-title":"Undiagnosed adult T-cell leukemia\/lymphoma in central Brooklyn, NY","volume":"5","author":"Welles","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jaad.2018.10.072_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib60","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jaad.2018.10.072_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2018.10.072_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v8030074","article-title":"Molecular mechanisms of HTLV-1 cell-to-cell transmission","volume":"8","author":"Gross","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jaad.2018.10.072_bib63","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fmicb.2012.00378","article-title":"Pathways of cell-cell transmission of HTLV-1","volume":"3","author":"Pique","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaad.2009.10.021","article-title":"Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review","volume":"64","author":"Lee","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2010.04568.x","article-title":"Cutaneous manifestations associated with HTLV-1 infection","volume":"49","author":"Bittencourt","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib66","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/ijd.12170","article-title":"Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I)","volume":"53","author":"Dantas","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.det.2013.11.006","article-title":"Infective dermatitis associated with HTLV-1 mimics common eczemas in children and may be a prelude to severe systemic diseases","volume":"32","author":"Hlela","year":"2014","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2018.10.072_bib68","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.10.072_bib69","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","article-title":"Molecular mechanisms of cellular transformation by HTLV-1 Tax","volume":"24","author":"Grassmann","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2018.10.072_bib70","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1182\/blood-2011-03-345702","article-title":"How I treat adult T-cell leukemia\/lymphoma","volume":"118","author":"Bazarbachi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v8020034","article-title":"The role of HBZ in HTLV-1-induced oncogenesis","volume":"8","author":"Zhao","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.jaad.2018.10.072_bib72","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JOP.2017.021907","article-title":"Adult T-cell leukemia\/lymphoma","volume":"13","author":"Mehta-Shah","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jaad.2018.10.072_bib73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2015.09.004","article-title":"How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)?","volume":"14","author":"Bangham","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jaad.2018.10.072_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6120111","article-title":"Viral oncology: molecular biology and pathogenesis","volume":"6","author":"Mui","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaad.2018.10.072_bib75","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib76","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.10.072_bib77","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1346-8138.1999.tb02093.x","article-title":"Clinicopathologic analysis of 124 cases of adult T-cell leukemia\/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought","volume":"26","author":"Setoyama","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib78","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0076-6879(92)12016-J","article-title":"Photofootprinting DNA in\u00a0vitro","volume":"212","author":"Becker","year":"1992","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jaad.2018.10.072_bib79","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.2004.06274.x","article-title":"Clinicopathological features of cutaneous lesions of adult T-cell leukaemia\/lymphoma","volume":"152","author":"Yamaguchi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib80","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib81","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1346-8138.2008.00465.x","article-title":"New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia\/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types","volume":"35","author":"Amano","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1346-8138.2003.tb00451.x","article-title":"Cutaneous type of adult T cell leukemia\/lymphoma: a new entity among cutaneous lymphomas","volume":"30","author":"Yagi","year":"2003","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/cup.13078","article-title":"Indolent, waxing and waning cutaneous presentation of HTLV-1-associated adult T-cell leukemia\/lymphoma in an HIV-1-positive patient","volume":"45","author":"Richey","year":"2018","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2018.10.072_bib84","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-4632.2008.03526.x","article-title":"Specific cutaneous manifestations in adult T-cell leukemia\/lymphoma","volume":"47","author":"Pezeshkpoor","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib85","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.3390\/v7122960","article-title":"Recent advances in therapeutic approaches for adult T-cell leukemia\/lymphoma","volume":"7","author":"Kato","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.jaad.2018.10.072_bib86","first-page":"1250","article-title":"Current management of adult T-cell leukemia\/lymphoma","volume":"23","author":"Tobinai","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jaad.2018.10.072_bib87","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4939-6872-5_15","article-title":"Overview of targeted therapies for adult T-cell leukemia\/lymphoma","volume":"1582","author":"Nasr","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaad.2018.10.072_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.hoc.2016.11.005","article-title":"Adult T-cell leukemia\/lymphoma: a problem abroad and at home","volume":"31","author":"Dittus","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaad.2018.10.072_bib89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/cas.12617","article-title":"Recent advances in the treatment of adult T-cell leukemia-lymphomas","volume":"106","author":"Utsunomiya","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jaad.2018.10.072_bib90","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.clindermatol.2008.10.007","article-title":"Infective dermatitis","volume":"27","author":"Trope","year":"2009","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib91","first-page":"62","article-title":"Adult-onset infective dermatitis associated with HTLV-I. Clinical and immunopathological aspects of two cases","volume":"16","author":"Bittencourt","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib92","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/exd.12007","article-title":"HTLV-1-associated infective dermatitis: updates on the pathogenesis","volume":"21","author":"McGill","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib93","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2018.10.072_bib94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fmicb.2016.00151","article-title":"Co-infections and pathogenesis of KSHV-associated malignancies","volume":"7","author":"Thakker","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib95","doi-asserted-by":"crossref","first-page":"e1006256","DOI":"10.1371\/journal.ppat.1006256","article-title":"Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism","volume":"13","author":"Sychev","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaad.2018.10.072_bib96","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fmicb.2012.00141","article-title":"Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers","volume":"3","author":"Dittmer","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaad.2018.10.072_bib97","article-title":"Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant","author":"Vangipuram","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib98","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/00313020310001602657","article-title":"Immunohistochemical detection of the human herpes virus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma","volume":"35","author":"Hong","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.jaad.2018.10.072_bib99","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13555-016-0152-3","article-title":"An update on Kaposi's sarcoma: epidemiology, pathogenesis and treatment","volume":"6","author":"Curtiss","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2018.10.072_bib100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(07)70036-0","article-title":"Management of AIDS-related Kaposi's sarcoma","volume":"8","author":"Di Lorenzo","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2018.10.072_bib101","first-page":"358","article-title":"Malignancies associated with Epstein\u2013Barr virus: pathobiology, clinical features, and evolving treatments","volume":"12","author":"Neparidze","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.jaad.2018.10.072_bib102","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/emm.2014.105","article-title":"Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorders","volume":"47","author":"Cai","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaad.2018.10.072_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2015.08.007","article-title":"A. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment","volume":"369","author":"Petrara","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaad.2018.10.072_bib104","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2007-10-117655","article-title":"LMP1 signaling can replace CD40 signaling in B cells in\u00a0vivo and has unique features of inducing class-switch recombination to IgG1","volume":"111","author":"Rastelli","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib105","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1128\/JVI.03001-14","article-title":"Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines","volume":"89","author":"Coleman","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.jaad.2018.10.072_bib106","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/v4091537","article-title":"Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival","volume":"4","author":"Frappier","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jaad.2018.10.072_bib107","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/ijc.27845","article-title":"Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment","volume":"132","author":"Cohen","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2018.10.072_bib108","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2018.10.072_bib109","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1634\/theoncologist.11-4-375","article-title":"Burkitt's lymphoma: clinicopathologic features and differential diagnosis","volume":"11","author":"Ferry","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2018.10.072_bib110","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.mayocp.2015.07.005","article-title":"Hodgkin lymphoma: diagnosis and treatment","volume":"90","author":"Ansell","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2018.10.072_bib111","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-3-319-13150-4_13","article-title":"Post-transplant lymphoproliferative disorders","volume":"165","author":"Singavi","year":"2015","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.jaad.2018.10.072_bib112","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/DAD.0000000000000144","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma: clinical and pathological characteristics","volume":"37","author":"Botros","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2018.10.072_bib113","doi-asserted-by":"crossref","first-page":"627401","DOI":"10.1155\/2010\/627401","article-title":"Extranodal natural-killer\/T-cell lymphoma, nasal type","volume":"2010","author":"Gill","year":"2010","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jaad.2018.10.072_bib114","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1746-1596-8-72","article-title":"Hydroa vacciniforme-like lymphoma of an adult: a case report with review of the literature","volume":"8","author":"Wang","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jaad.2018.10.072_bib115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/bjh.15263","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"182","author":"DeStefano","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2018.10.072_bib116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2004.12.012","article-title":"Post-transplant cutaneous T-cell lymphomas","volume":"56","author":"Lok","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaad.2018.10.072_bib117","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation","volume":"54","author":"Ravat","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib118","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series","volume":"13","author":"Se\u00e7kin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2018.10.072_bib119","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib120","doi-asserted-by":"crossref","first-page":"e0319","DOI":"10.1097\/MD.0000000000010319","article-title":"Hydroa vacciniforme-like cutaneous T-cell lymphoma in a child: a case report","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2018.10.072_bib121","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/qjmed\/hcw137","article-title":"Hydroa vacciniforme-like lymphoma","volume":"109","author":"Qiao","year":"2016","journal-title":"QJM"},{"key":"10.1016\/j.jaad.2018.10.072_bib122","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2011.02.037","article-title":"Serum sickness-like reaction: histopathology and case report","volume":"65","author":"Tolpinrud","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib123","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","article-title":"Polyarteritis nodosa: a contemporary overview","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2018.10.072_bib124","first-page":"53","article-title":"Diagnosis and treatment of lichen planus","volume":"84","author":"Usatine","year":"2011","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2018.10.072_bib125","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2012-05-423186","article-title":"The porphyrias: advances in diagnosis and treatment","volume":"120","author":"Balwani","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2018.10.072_bib126","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1358\/dot.2012.48.10.1885878","article-title":"Mogamulizumab for the treatment of adult T-cell leukemia\/lymphoma","volume":"48","author":"de Lartigue","year":"2012","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.jaad.2018.10.072_bib127","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.134.4.439","article-title":"Clinical, pathologic, and immunologic features of human T-lymphotrophic virus type I-associated infective dermatitis in children","volume":"134","author":"La Grenade","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib128","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaad.2006.02.030","article-title":"Cutaneous involvement by Burkitt lymphoma","volume":"54","author":"Jacobson","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib129","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2005.11.1055","article-title":"Cutaneous Hodgkin\u2019s disease","volume":"58","author":"Introcaso","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.amjmed.2017.02.006","article-title":"Inner peace: cutaneous polyarteritis nodosa","volume":"130","author":"Parperis","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2018.10.072_bib131","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jdcr.2018.04.004","article-title":"Hepatitis C mixed cryoglobulinemia with undetectable viral load: a case series","volume":"4","author":"Kartha","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2018.10.072_bib132","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jaad.2003.09.017","article-title":"Necrolytic acral erythema: response to combination therapy with interferon and ribavirin","volume":"50","author":"Hivnor","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib133","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdcr.2016.12.005","article-title":"Treatment with ledipasvir-sofosbuvir for hepatitis C resulting in improvement of lichen planus","volume":"3","author":"Ansari","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2018.10.072_bib134","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jaad.2012.12.958","article-title":"Cutaneous manifestations of angioimmunoblastic T-cell lymphoma","volume":"69","author":"Jacobson","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2018.10.072_bib135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jdcr.2016.05.020","article-title":"CD56- extranodal natural killer (NK)\/T-cell lymphoma, nasal type presenting as skin ulcers in a white man","volume":"2","author":"Vainder","year":"2016","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2018.10.072_bib136","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jdcr.2015.04.016","article-title":"An unusual case of cytotoxic peripheral T-cell lymphoma","volume":"1","author":"Wang","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2018.10.072_bib137","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jdcr.2017.10.023","article-title":"Adult-onset hydroa vacciniforme-like lymphoma in a long-term resident of the United States","volume":"4","author":"Yu","year":"2018","journal-title":"JAAD Case Rep"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962218329645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:00:53Z","timestamp":1775286053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962218329645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0190962218329645"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.072","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2018.10.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(19)30815-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}